Expression of MAGE genes in primary and metastatic cutaneous melanoma
about
MAGE-RING protein complexes comprise a family of E3 ubiquitin ligasesA testicular antigen aberrantly expressed in human cancers detected by autologous antibody screeningHuman tumor antigens recognized by T lymphocytesTargeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challengesmRNA expression of tumor-associated antigens in melanoma tissues and cell linesA randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)CancerEST: a web-based tool for automatic meta-analysis of public EST dataMultiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancerExpression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factorsCancer-testis (CT) antigen expression in medulloblastoma.Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cellsHigh expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer.Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.Aberrant DNA methylation in malignant melanomaCancer/testis antigens: structural and immunobiological properties.MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification.Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools.Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implicationsThe gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisWhen MAGE meets RING: insights into biological functions of MAGE proteins.Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells.MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.MAGE A3 antigen-specific cancer immunotherapeutic.The biology of cancer testis antigens: putative function, regulation and therapeutic potentialAntigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.MAGE-A3: an immunogenic target used in clinical practice.The MAGE protein family and cancer.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.
P2860
Q24300816-EAD1DC9E-6AB3-45E8-B9FD-BE78A9A29F22Q24564781-50123EE3-E57F-4E07-B08E-25E4A72681C9Q24678508-4A58525F-849A-421B-8EA6-C55932004CBBQ26774074-7272A58E-C311-40C6-9CB7-876073499ABCQ28218733-34333921-B0AD-4B69-A56F-FD02B409D779Q30411499-1E41B773-AD02-49E2-9C36-896FE6702FC4Q30796869-0D2D3C85-C68D-4C3A-BDAA-E89EC694C65BQ33855568-CAAAB181-5275-48F8-AA41-79D9F844796DQ33943139-D35F3732-C164-4321-899D-FA2B9D1F1850Q34015590-154C656B-363F-4812-8017-29F5300DC245Q34111725-0F94B273-DEBA-4F2A-A5CD-047D8C81C7C9Q34111864-4766CA29-CF75-4F6F-92F1-5E6CC0DFF272Q34182555-28CED3A8-BF96-4E5D-B986-E065A65FD5C3Q34235940-0798AF1F-8842-4A85-A16B-E02A4744D10EQ34353878-0FA780F8-6513-432F-914D-3058D96F813FQ34516587-83A7DC9F-29A4-4BD9-808A-5A99E5A6E466Q34568997-B2E7021A-2A71-4721-A405-742A4928D771Q35764937-B0E948AE-0A2C-48BC-8C99-7E6A547E0E45Q35789880-958FDC6F-1600-48D6-BE8C-DA952D776F3CQ35933899-3C7054D1-134B-43B7-8BDC-0B6BF3B8346AQ36110300-D10C4107-0685-41F9-B544-594A254480ACQ36237251-5031FA24-97AE-4298-9A1D-6BC9D6D4071CQ36623761-994E6C46-2267-43ED-A32A-255C86AED8B6Q36691376-3931D20D-079E-4918-9252-B18CF2BD6916Q36922812-49BE6EF6-213C-41CF-9932-BEB33B63BD9DQ37038420-2069BE6F-33F2-4D0D-B1F7-8FECC432BC6FQ37281267-85BB73B6-5F74-447A-9E49-5219C54C8B8BQ37491118-8FC95C61-A8C9-4B91-9A2E-607DE1BFFB4EQ37544387-7FBF4632-BFF5-40A5-B76C-AEA89D9454B9Q37699127-31F34669-04B6-483C-92F0-E81C72B65C21Q37737327-29944E28-E2F3-4B4A-A070-7F02C9E0A4F9Q37773275-069D1337-952A-417B-8D35-156B4903C9A6Q37849976-118E54EE-4AD2-4A34-8C3B-E61831301AD3Q37952804-3F82C10A-F391-442F-A034-99D662D3D429Q38465242-B03A1ACE-A7C1-41B1-BE69-F6B85046268FQ38534721-660C6642-D2EA-4A78-8783-B6977531833AQ38581531-C7C4A56C-5294-4F7C-A240-9700FEEC6CF9Q38948541-18FD5B54-57DB-4C4B-8000-A8B1E1AB766AQ39113639-EE8B5BC5-6222-4BD0-9E2C-54EBBE0446FAQ39181769-66ABE1AA-3D47-4934-A387-D468A8B1743A
P2860
Expression of MAGE genes in primary and metastatic cutaneous melanoma
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@ast
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@en
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@nl
type
label
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@ast
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@en
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@nl
prefLabel
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@ast
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@en
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@nl
P2093
P3181
P356
P1476
Expression of MAGE genes in primary and metastatic cutaneous melanoma
@en
P2093
A Bourlond
F Brasseur
R Vanwijck
P304
P3181
P356
10.1002/IJC.2910630313
P407
P577
1995-11-03T00:00:00Z